Doximity director awarded 9,750 RSUs after grant correction

Doximity, Inc. director Benjamin M. Regina reported an equity award of 9,750 restricted stock units (RSUs) of Class A Common Stock granted on November 15, 2025 under the 2021 Stock Option and Incentive Plan.

Rhea-AI Filing Summary

Doximity, Inc. director Benjamin M. Regina reported an equity award of 9,750 restricted stock units (RSUs) of Class A Common Stock granted on November 15, 2025 under the 2021 Stock Option and Incentive Plan. The award reflects a correction from an original 31,064-RSU grant, of which 21,314 RSUs were deemed not validly granted and void ab initio. The 9,750 RSUs vest in four installments through November 15, 2026, and each RSU converts into one share upon vesting, leaving Regina with 29,589 shares held directly after the award.

Insider Trade Summary

Grant/Award: 9,750 shares

Grant/Award 1 txn

Insider Benjamin Regina M.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1	9,750	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 29,589 shares (Direct)

Footnotes (1)

1. F1. These shares represent restricted stock units (each, an "RSU") granted on November 15, 2025 pursuant to the Doximity, Inc. 2021 Stock Option and Incentive Plan (the "2021 Plan"). The Compensation Committee subsequently determined that 21,314 of the originally granted 31,064 RSUs were not validly granted under the 2021 Plan and were therefore void ab initio. The 9,750 RSUs vest as follows, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date: 3,106 RSUs on February 15, 2026, 3,107 RSUs on May 15, 2026, 3,106 RSUs on August 15, 2026 and 431 RSUs on November 15, 2026. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Key Figures

RSUs granted: 9,750 RSUs Shares held after award: 29,589 shares Original RSU grant: 31,064 RSUs +5 more

8 metrics

RSUs granted 9,750 RSUs Restricted stock units of Class A Common Stock granted on November 15, 2025

Shares held after award 29,589 shares Direct holdings of Class A Common Stock following the RSU award

Original RSU grant 31,064 RSUs Initial RSU grant before correction under the 2021 Plan

RSUs voided 21,314 RSUs Portion of the original grant deemed not validly granted and void ab initio

First vesting tranche 3,106 RSUs Vest on February 15, 2026, subject to continued service

Second vesting tranche 3,107 RSUs Vest on May 15, 2026, subject to continued service

Third vesting tranche 3,106 RSUs Vest on August 15, 2026, subject to continued service

Final vesting tranche 431 RSUs Vest on November 15, 2026, subject to continued service

Key Terms

restricted stock units, void ab initio, 2021 Stock Option and Incentive Plan, Class A Common Stock

4 terms

restricted stock units financial

"These shares represent restricted stock units (each, an "RSU") granted on November 15, 2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

void ab initio regulatory

"were not validly granted under the 2021 Plan and were therefore void ab initio"

2021 Stock Option and Incentive Plan financial

"granted on November 15, 2025 pursuant to the Doximity, Inc. 2021 Stock Option and Incentive Plan"

Class A Common Stock financial

"Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity award did Doximity (DOCS) director Benjamin M. Regina report?

Benjamin M. Regina reported an award of 9,750 RSUs of Doximity Class A Common Stock granted on November 15, 2025 under the 2021 Stock Option and Incentive Plan, with no purchase price and settlement in shares upon vesting.

How was the original RSU grant to Doximity (DOCS) director Benjamin M. Regina corrected?

An initial grant of 31,064 RSUs was adjusted after the Compensation Committee determined that 21,314 RSUs were not validly granted under the 2021 Plan and were void ab initio, leaving a valid award of 9,750 RSUs.

What is the vesting schedule for Benjamin M. Regina’s 9,750 Doximity (DOCS) RSUs?

The 9,750 RSUs vest in four tranches: 3,106 on February 15, 2026; 3,107 on May 15, 2026; 3,106 on August 15, 2026; and 431 on November 15, 2026, subject to continued service.

What does each RSU granted to Doximity (DOCS) director Benjamin M. Regina represent?

Each RSU represents a contingent right to receive one share of Doximity’s Class A Common Stock, delivered as the RSUs vest, provided Benjamin M. Regina continues to provide service through each vesting date.

How many Doximity (DOCS) shares does Benjamin M. Regina hold after this RSU grant?

Following the reported award, Benjamin M. Regina holds 29,589 shares of Doximity Class A Common Stock directly, reflecting his position after the adjusted 9,750-RSU grant under the 2021 Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/14/2026 - 07:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Benjamin Regina M.

(Last) (First) (Middle)

C/O DOXIMITY, INC.

500 THIRD STREET

(Street)

SAN FRANCISCO CALIFORNIA 94107

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/15/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
11/18/2025

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/15/2025		A		9,750(1)	A	$0	29,589	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units (each, an "RSU") granted on November 15, 2025 pursuant to the Doximity, Inc. 2021 Stock Option and Incentive Plan (the "2021 Plan"). The Compensation Committee subsequently determined that 21,314 of the originally granted 31,064 RSUs were not validly granted under the 2021 Plan and were therefore void ab initio. The 9,750 RSUs vest as follows, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date: 3,106 RSUs on February 15, 2026, 3,107 RSUs on May 15, 2026, 3,106 RSUs on August 15, 2026 and 431 RSUs on November 15, 2026. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Remarks:

This Form 4/A amends and restates in its entirety the original Form 4, filed on November 18, 2025, to reflect the Compensation Committee's determination that 21,314 of the 31,064 RSUs originally reported were not validly granted under the 2021 Plan and were therefore void ab initio. This amendment reports only the 9,750 RSUs that the Compensation Committee determined were validly granted under the 2021 Plan.

	/s/ John Vaughan, Attorney-in-Fact	07/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)